Loading clinical trials...
Loading clinical trials...
Open-label Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Ustekinumab in Pediatric Participants
Conditions
Interventions
Ustekinumab
Locations
10
United States
Newport Huntington Medical Group
Huntington Beach, California, United States
Childrens Hospital Los Angeles
Los Angeles, California, United States
Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital
Chicago, Illinois, United States
Michigan Dermatology Institute
Waterford, Michigan, United States
Columbia University Medical Center
New York, New York, United States
Akron Children s Hospital
Akron, Ohio, United States
Start Date
May 24, 2022
Primary Completion Date
January 26, 2024
Completion Date
January 26, 2024
Last Updated
April 27, 2025
NCT07474792
NCT06857942
NCT06979453
NCT07449234
NCT07471048
NCT07116967
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions